SLC29A1 and choriocarcinoma: The study successfully demonstrated that ENT‐1‐targeted MTX‐loaded polymersomes significantly improve drug delivery and antitumor efficacy in JEG‐3 mouse model, for application in choriocarcinoma treatment.